TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. DRUG OF ABUSE TESTING MARKET, BY TEST TYPE (USD BILLION)
6.1. Urine Testing
6.2. Blood Testing
6.3. Saliva Testing
6.4. Hair Testing
7. DRUG OF ABUSE TESTING MARKET, BY METHODOLOGY (USD BILLION)
7.1. Immunoassays
7.2. Chromatography
7.3. Spectrometry
8. DRUG OF ABUSE TESTING MARKET, BY END USE (USD BILLION)
8.1. Hospitals
8.2. Laboratories
8.3. Workplaces
8.4. Home Care
9. DRUG OF ABUSE TESTING MARKET, BY SUBSTANCE TESTED (USD BILLION)
9.1. Cannabis
9.2. Cocaine
9.3. Opiates
9.4. Amphetamines
9.5. Phencyclidine
10. DRUG OF ABUSE TESTING MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Drug of Abuse Testing Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Drug of Abuse Testing Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Roche Holdings
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Alere
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Abbott Laboratories
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Quest Diagnostics
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Thermo Fisher Scientific
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Cannabis Testing Labs
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Psychemedics Corporation
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. ZyCam
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Drägerwerk AG
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. ACADIA Pharmaceuticals
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Orasure Technologies
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. LabCorp
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Mediware Information Systems
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. American Bio Medica Corporation
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Siemens Healthineers
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 3. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 4. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 5. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 6. NORTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7. US DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 8. US DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 9. US DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 10. US DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 11. US DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12. CANADA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 13. CANADA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 14. CANADA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 15. CANADA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 16. CANADA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17. EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 18. EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 19. EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 20. EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 21. EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22. GERMANY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 23. GERMANY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 24. GERMANY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 25. GERMANY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 26. GERMANY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27. UK DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 28. UK DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 29. UK DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 30. UK DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 31. UK DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32. FRANCE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 33. FRANCE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 34. FRANCE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 35. FRANCE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 36. FRANCE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 38. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 39. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 40. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 41. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42. ITALY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 43. ITALY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 44. ITALY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 45. ITALY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 46. ITALY DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47. SPAIN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 48. SPAIN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 49. SPAIN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 50. SPAIN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 51. SPAIN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52. REST OF EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 53. REST OF EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 54. REST OF EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 55. REST OF EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 56. REST OF EUROPE DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 58. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 59. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 60. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 61. APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62. CHINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 63. CHINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 64. CHINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 65. CHINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 66. CHINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67. INDIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 68. INDIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 69. INDIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 70. INDIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 71. INDIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72. JAPAN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 73. JAPAN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 74. JAPAN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 75. JAPAN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 76. JAPAN DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 77. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 78. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 79. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 80. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 81. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 82. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 83. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 84. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 85. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 86. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 87. THAILAND DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 88. THAILAND DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 89. THAILAND DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 90. THAILAND DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 91. THAILAND DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 92. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 93. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 94. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 95. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 96. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 97. REST OF APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 98. REST OF APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 99. REST OF APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 100. REST OF APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 101. REST OF APAC DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 102. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 103. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 104. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 105. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 106. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 107. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 108. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 109. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 110. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 111. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 112. MEXICO DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 113. MEXICO DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 114. MEXICO DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 115. MEXICO DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 116. MEXICO DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 117. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 118. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 119. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 120. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 121. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 127. MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 128. MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 129. MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 130. MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 131. MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 132. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 133. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 134. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 135. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 136. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 137. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 138. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 139. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 140. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 141. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 142. REST OF MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD BILLIONS)
TABLE 143. REST OF MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY METHODOLOGY, 2019-2035 (USD BILLIONS)
TABLE 144. REST OF MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD BILLIONS)
TABLE 145. REST OF MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY SUBSTANCE TESTED, 2019-2035 (USD BILLIONS)
TABLE 146. REST OF MEA DRUG OF ABUSE TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS
FIGURE 3. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 4. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 5. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 6. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 7. US DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 9. CANADA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 10. CANADA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 11. CANADA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 12. CANADA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE DRUG OF ABUSE TESTING MARKET ANALYSIS
FIGURE 14. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 15. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 16. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 17. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 18. GERMANY DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 20. UK DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 21. UK DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 22. UK DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 23. UK DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 25. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 26. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 27. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 28. FRANCE DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 30. RUSSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 31. RUSSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 32. RUSSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 33. RUSSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 35. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 36. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 37. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 38. ITALY DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 40. SPAIN DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 41. SPAIN DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 42. SPAIN DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 43. SPAIN DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 45. REST OF EUROPE DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 46. REST OF EUROPE DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 47. REST OF EUROPE DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 48. REST OF EUROPE DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC DRUG OF ABUSE TESTING MARKET ANALYSIS
FIGURE 50. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 51. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 52. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 53. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 54. CHINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 56. INDIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 57. INDIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 58. INDIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 59. INDIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 61. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 62. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 63. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 64. JAPAN DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 66. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 67. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 68. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 69. SOUTH KOREA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 71. MALAYSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 72. MALAYSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 73. MALAYSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 74. MALAYSIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 76. THAILAND DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 77. THAILAND DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 78. THAILAND DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 79. THAILAND DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 81. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 82. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 83. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 84. INDONESIA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 86. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 87. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 88. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 89. REST OF APAC DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS
FIGURE 91. BRAZIL DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 92. BRAZIL DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 93. BRAZIL DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 94. BRAZIL DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 95. BRAZIL DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 97. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 98. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 99. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 100. MEXICO DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 102. ARGENTINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 103. ARGENTINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 104. ARGENTINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 105. ARGENTINA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 107. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 108. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 109. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 110. REST OF SOUTH AMERICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA DRUG OF ABUSE TESTING MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 113. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 114. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 115. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 116. GCC COUNTRIES DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 118. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 119. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 120. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 121. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY TEST TYPE
FIGURE 123. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY METHODOLOGY
FIGURE 124. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY END USE
FIGURE 125. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY SUBSTANCE TESTED
FIGURE 126. REST OF MEA DRUG OF ABUSE TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF DRUG OF ABUSE TESTING MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF DRUG OF ABUSE TESTING MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: DRUG OF ABUSE TESTING MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: DRUG OF ABUSE TESTING MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: DRUG OF ABUSE TESTING MARKET
FIGURE 133. DRUG OF ABUSE TESTING MARKET, BY TEST TYPE, 2025 (% SHARE)
FIGURE 134. DRUG OF ABUSE TESTING MARKET, BY TEST TYPE, 2019 TO 2035 (USD Billions)
FIGURE 135. DRUG OF ABUSE TESTING MARKET, BY METHODOLOGY, 2025 (% SHARE)
FIGURE 136. DRUG OF ABUSE TESTING MARKET, BY METHODOLOGY, 2019 TO 2035 (USD Billions)
FIGURE 137. DRUG OF ABUSE TESTING MARKET, BY END USE, 2025 (% SHARE)
FIGURE 138. DRUG OF ABUSE TESTING MARKET, BY END USE, 2019 TO 2035 (USD Billions)
FIGURE 139. DRUG OF ABUSE TESTING MARKET, BY SUBSTANCE TESTED, 2025 (% SHARE)
FIGURE 140. DRUG OF ABUSE TESTING MARKET, BY SUBSTANCE TESTED, 2019 TO 2035 (USD Billions)
FIGURE 141. DRUG OF ABUSE TESTING MARKET, BY REGIONAL, 2025 (% SHARE)
FIGURE 142. DRUG OF ABUSE TESTING MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
